March 17, 2026
(Wired) – Researchers in Japan pioneered reprogrammed cells 20 years ago. Now the country has given the first-ever authorizations to manufacture and sell medical products based on the technology. SMaRT, located in Suita City, Osaka Prefecture, is responsible for the … Read More
May 15, 2025
(Nature) – Researchers have coaxed stem cells to grow into amniotic sacs filled with fluid. The model sacs, which grew to roughly the same size as a four-week-old sac surrounding a developing embryo, could be used to study the protective … Read More
April 10, 2025
(NPR) – Scientists have re-created a pain pathway in the brain by growing four key clusters of human nerve cells in a dish. This laboratory model could be used to help explain certain pain syndromes, and offer a new way … Read More
March 31, 2025
(MIT Technology Review) – Although it may seem like science fiction, recent technological progress has pushed this concept into the realm of plausibility. Pluripotent stem cells, one of the earliest cell types to form during development, can give rise to … Read More
December 20, 2024
(Nature) – More than 100 clinical trials put stem cells for regenerative medicine to the test. It’s a turning point for a field beset with ethical and political controversy. The study is one of more than 100 clinical trials exploring … Read More
September 27, 2024
(Nature) – A 25-year-old woman with type 1 diabetes started producing her own insulin less than three months after receiving a transplant of reprogrammed stem cells. She is the first person with the disease to be treated using cells that … Read More
September 8, 2023
August 21, 2023
July 17, 2023
June 28, 2023
March 23, 2023
October 27, 2022
October 13, 2022
August 31, 2022
May 13, 2022
August 20, 2021
February 26, 2021
August 24, 2020
July 27, 2020
May 14, 2020
May 12, 2020
February 5, 2020
October 23, 2019
September 3, 2019
May 7, 2019
(The Scientist) – In a first-of-its-kind clinical trial, a natural killer cell immunotherapy derived from induced pluripotent stem cells is being tested for safety in 64 patients with a variety of solid tumors. The first patients received the cells in … Read More
